Provided by Tiger Trade Technology Pte. Ltd.

Anaptysbio Inc

44.95
+1.152.63%
Post-market: 44.88-0.0700-0.16%17:50 EST
Volume:318.25K
Turnover:14.27M
Market Cap:1.24B
PE:-15.63
High:45.39
Open:43.71
Low:43.60
Close:43.80
52wk High:46.56
52wk Low:12.21
Shares:27.69M
Float Shares:14.25M
Volume Ratio:0.73
T/O Rate:2.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8757
EPS(LYR):-5.1170
ROE:-308.02%
ROA:-4.23%
PB:-42.31
PE(LYR):-8.78

Loading ...

Mar 24, 2025

Major Issues Report

Form 8-K - Current report
Feb 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Major Issues Report

Form 8-K - Current report
Feb 12, 2025

Major Issues Report

Form 8-K - Current report
Feb 03, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Major Issues Report

Form 8-K - Current report
Nov 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Correspondence

Form CORRESP - Correspondence
Nov 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2024

Major Issues Report

Form 8-K - Current report
Sep 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities